Philip Morris International aims to be 66% smoke-free ... In China, it licenses sales and production to CNTC (China National Tobacco Corporation), the state-owned monopoly of tobacco products ...

Tobacco company Philip Morris International (NYSE:PM) will be reporting earnings tomorrow before market open. Here’s what investors should know. Philip Morris beat analysts’ revenue ...

Philip Morris International remains a strong buy due to its dominance in smoke-free products like IQOS and ZYN, outperforming the S&P 500 by over 20% since my last article. The latest earnings ...

Philip Morris International is a growth stock in a ... licenses its Marlboro brand to the China National Tobacco Company (CNTC), which manufactures it along with its own Chinese domestic brands.

A month has gone by since the last earnings report for Philip Morris (PM). Shares have added about 3% in that time frame, underperforming the S&P 500. Will the recent positive trend continue ...

while Marlboro seller Philip Morris International (PM) operates a joint venture with state-owned China National Tobacco Corporation (CNTC). All major American fast-food and coffee chains ...

Altria and Philip Morris share a history and sell the same brands, but in different parts of the world. Philip Morris has entered the U.S. market, competing with Altria in non-cigarette businesses.

Three years after raising health groups’ suspicions by acquiring Vectura, a British pharmaceutical firm that makes asthma inhalers, cigarette giant Philip Morris International has made a deal to ...

Shares of Philip Morris International are on track for an all-time closing high, after the company reported strong sales growth for its Marlboro cigarettes and Zyn nicotine pouches. The tobacco ...

Philip Morris International said Tuesday it is planning to invest $600 million to open a manufacturing plant in Colorado to keep up with steep demand for Zyn nicotine pouches. The tobacco giant ...

Sept 17 (Reuters) - Philip Morris International's (PM.N), opens new tab Vectura Fertin Pharma said on Tuesday it would sell its asthma inhaler maker Vectura Group to Molex Asia Holdings for 150 ...